Joseph H. Capper net worth and biography

Joseph Capper Biography and Net Worth

CEO of MiMedx Group

Mr. Capper joined MIMEDX in January 2023 to lead the Company as Chief Executive Officer and Director. A highly experienced and accomplished healthcare executive, he brings nearly 30 years of experience in MedTech and Life Sciences leadership roles along with a track record of substantial value creation.

Mr. Capper has successfully led several organizations, most recently serving as the CEO of BioTelemetry, guiding the company through a significant turn-around, which culminated with its acquisition by Royal Philips for $2.8 billion. Prior to BioTelemetry, he served as President and CEO of both Home Diagnostics and CCS Medical. Mr. Capper brings with him a wealth of commercial experience, having held several leadership roles earlier in his career during the decade he spent with Bayer AG. Additionally, he was an officer in the U.S. Navy serving with distinction as a naval aviator.

Mr. Capper received his undergraduate degree in Accounting from West Chester University and MBA in
International Finance from George Washington University.

What is Joseph H. Capper's net worth?: The estimated net worth of Joseph H. Capper is at least $3.46 million as of May 2nd, 2025. Mr. Capper owns 529,530 shares of MiMedx Group stock worth more than $3,457,831 as of June 10th. This net worth evaluation does not reflect any other assets that Mr. Capper may own. Additionally, Mr. Capper receives an annual salary of $1,550,000.00 as CEO at MiMedx Group. Learn More about Joseph H. Capper's net worth.
How old is Joseph H. Capper?: Mr. Capper is currently 60 years old. There are 6 older executives and no younger executives at MiMedx Group. Learn More on Joseph H. Capper's age.
What is Joseph H. Capper's salary?: As the CEO of MiMedx Group, Inc., Mr. Capper earns $1,550,000.00 per year. Learn More on Joseph H. Capper's salary.
How do I contact Joseph H. Capper?: The corporate mailing address for Mr. Capper and other MiMedx Group executives is 1775 W OAK COMMONS COURT NE, MARIETTA GA, 30062. MiMedx Group can also be reached via phone at (770) 651-9100 and via email at [email protected]. Learn More on Joseph H. Capper's contact information.
Has Joseph H. Capper been buying or selling shares of MiMedx Group?: Within the last three months, Joseph H. Capper has bought $1,268,000.00 in MiMedx Group stock. Most recently, on Friday, May 2nd, Joseph H. Capper bought 200,000 shares of MiMedx Group stock. The stock was acquired at an average cost of $6.34 per share, with a total value of $1,268,000.00. Following the completion of the transaction, the chief executive officer now directly owns 529,530 shares of the company's stock, valued at $3,357,220.20. Learn More on Joseph H. Capper's trading history.
Who are MiMedx Group's active insiders?: MiMedx Group's insider roster includes Joseph Capper (CEO), William Hulse, IV (General Counsel and Chief Administrative and Compliance Officer), Kimberly Maersk-Moller (Chief Commercial Officer), Doug Rice (CFO), and Ricci Whitlow (COO). Learn More on MiMedx Group's active insiders.
Are insiders buying or selling shares of MiMedx Group?: In the last twelve months, MiMedx Group insiders bought shares 1 times. They purchased a total of 200,000 shares worth more than $1,268,000.00. In the last twelve months, insiders at the sold shares 5 times. They sold a total of 144,018 shares worth more than $1,130,312.34. The most recent insider tranaction occured on May, 2nd when CEO Joseph H Capper bought 200,000 shares worth more than $1,268,000.00. Insiders at MiMedx Group own 1.7% of the company. Learn More about insider trades at MiMedx Group.
Information on this page was last updated on 5/2/2025.

Joseph H. Capper Insider Trading History at MiMedx Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/2/2025	Buy	200,000	$6.34	$1,268,000.00	529,530

Joseph H. Capper Buying and Selling Activity at MiMedx Group

MiMedx Group Company Overview

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Today's Range

Now: $6.53

$6.40

$6.59

50 Day Range

MA: $6.80

$6.32

$7.43

2 Week Range

Now: $6.53

$5.47

$10.14

Volume

340,554 shs

Average Volume

684,930 shs

Market Capitalization

$964.49 million

P/E Ratio

11.87

Dividend Yield

N/A

Beta

1.82

Joseph Capper Biography and Net Worth

What is Joseph H. Capper's net worth?

How old is Joseph H. Capper?

What is Joseph H. Capper's salary?

How do I contact Joseph H. Capper?

Has Joseph H. Capper been buying or selling shares of MiMedx Group?

Who are MiMedx Group's active insiders?

Are insiders buying or selling shares of MiMedx Group?